Belcher JD - Search Results

1

Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.

Beckman JD, Abdullah F, Chen C, Kirchner R, Rivera-Rodriguez D, Kiser ZM, Nguyen A, Zhang P, Nguyen J, Hebbel RP, Belcher JD, Vercellotti GM. Beckman JD, et al. Among authors: belcher jd. Front Immunol. 2021 Jan 19;11:613278. doi: 10.3389/fimmu.2020.613278. eCollection 2020. Front Immunol. 2021. PMID: 33542720 Free PMC article.

2

Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury.

Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM. Balla G, et al. Among authors: belcher jd. Arterioscler Thromb. 1991 Nov-Dec;11(6):1700-11. doi: 10.1161/01.atv.11.6.1700. Arterioscler Thromb. 1991. PMID: 1931871

3

Oxidized low-density lipoproteins and endothelium: oral vitamin E supplementation prevents oxidized low-density lipoprotein-mediated vascular injury.

Balla J, Belcher JD, Balla G, Jacob HS, Vercellotti GM. Balla J, et al. Among authors: belcher jd. Trans Assoc Am Physicians. 1993;106:128-33. Trans Assoc Am Physicians. 1993. PMID: 8036736

4

Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro.

Belcher JD, Balla J, Balla G, Jacobs DR Jr, Gross M, Jacob HS, Vercellotti GM. Belcher JD, et al. Arterioscler Thromb. 1993 Dec;13(12):1779-89. doi: 10.1161/01.atv.13.12.1779. Arterioscler Thromb. 1993. PMID: 8241098

5

Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia.

Belcher JD, Marker PH, Geiger P, Girotti AW, Steinberg MH, Hebbel RP, Vercellotti GM. Belcher JD, et al. J Lab Clin Med. 1999 Jun;133(6):605-12. doi: 10.1016/s0022-2143(99)90191-9. J Lab Clin Med. 1999. PMID: 10360636

6

Effects of anti-rheumatic gold salts on NF-kappa B mobilization and tumour necrosis factor-alpha (TNF-alpha)-induced neutrophil-dependent cytotoxicity for human endothelial cells.

Bratt J, Belcher J, Vercellotti GM, Palmblad J. Bratt J, et al. Clin Exp Immunol. 2000 Apr;120(1):79-84. doi: 10.1046/j.1365-2249.2000.01190.x. Clin Exp Immunol. 2000. PMID: 10759767 Free PMC article.

7

Reperfusion injury pathophysiology in sickle transgenic mice.

Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, Hebbel RP. Osarogiagbon UR, et al. Among authors: belcher jd. Blood. 2000 Jul 1;96(1):314-20. Blood. 2000. PMID: 10891467 Free article.

8

Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.

Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM. Belcher JD, et al. Blood. 2000 Oct 1;96(7):2451-9. Blood. 2000. PMID: 11001897 Free article.

9

Transgenic sickle mice have vascular inflammation.

Belcher JD, Bryant CJ, Nguyen J, Bowlin PR, Kielbik MC, Bischof JC, Hebbel RP, Vercellotti GM. Belcher JD, et al. Blood. 2003 May 15;101(10):3953-9. doi: 10.1182/blood-2002-10-3313. Epub 2003 Jan 23. Blood. 2003. PMID: 12543857 Free article.

10

Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice.

Kaul DK, Liu XD, Choong S, Belcher JD, Vercellotti GM, Hebbel RP. Kaul DK, et al. Among authors: belcher jd. Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H293-301. doi: 10.1152/ajpheart.01150.2003. Epub 2004 Mar 4. Am J Physiol Heart Circ Physiol. 2004. PMID: 15001449 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters